A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann ...

RedePHine phase 1/2 clinical trial initiation expected in first half of 2025CAMBRIDGE, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) ...

After years of struggling with alcohol dependence, Shana found a combination of treatment and counseling that works for her.

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of hepatotoxicity, following the Food and Drug Administration’s review of a ...

Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...

It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

The U.S. Food and Drug Administration (FDA) has issued its most serious warning -- a black-box warning -- for Veoza ...

Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...

For many people with early breast cancer (eBC), remission doesn’t mean everything goes back to normal. There are scars from ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.